Clinical Trials in Houston

Showing 11481-11500 of 17,885 trials

Health Benefits of Expressive Writing: Study One

NCT03546673

This study is a randomized controlled trial (RCT) with the aim of determining the cultural sensitivity, feasibility, and effectiveness of an expressive writing intervention for Chinese breast cancer survivors.

Breast CancerBreast Neoplasm

University of Houston96 participantsStarted Jul 2009

Los Angeles, California, United States • Houston, Texas, United States

COMPLETEDPhase 1< 1 mile

Open Label, Multi-center Study to Assess the Safety, Tolerability and Pharmacokinetics of CUDC-907 in Subjects With Advanced/Relapsed Solid Tumors

NCT02307240

This is a Phase I, open-label, multi-center trial designed to evaluate the safety, tolerability and pharmacokinetics of CUDC-907 administered orally to subjects with advanced/relapsed solid tumors.

Triple-Negative Breast CancerHigh-grade Serous Ovarian CancerSolid Tumors+1 more

Curis, Inc.43 participantsStarted Nov 2014

San Francisco, California, United States • Sarasota, Florida, United States • Boston, Massachusetts, United States +1 more locations

UNKNOWN< 1 mile

Cancer Patients Diagnosed With Unsuspected Venous Thromboembolism (VTE) on Routine Computed Tomography (CT) Scans

NCT00925808

This is a prospective study with the following objectives: Primary Objective: 1. To estimate the prevalence of unsuspected VTE in oncology patients on routine staging CT scans of the thorax, abdomen and pelvis. Secondary Objectives: 2. To identify symptoms commonly associated with VTE that are present in cancer patients undergoing routine staging CT scans with findings of unsuspected VTE. 3. To identify the risk factors and demographic characteristics in outpatient cancer patients associated with the development of unsuspected VTE. 4. To determine the incidence of recurrence of new VTE in patients with unsuspected VTE at 3 and 6 months of follow-up.

CancerVenous Thromboembolism

M.D. Anderson Cancer Center1,187 participantsStarted Jun 2009

Houston, Texas, United States

Health Benefits of Expressive Writing: Study One

Open Label, Multi-center Study to Assess the Safety, Tolerability and Pharmacokinetics of CUDC-907 in Subjects With Advanced/Relapsed Solid Tumors

Cancer Patients Diagnosed With Unsuspected Venous Thromboembolism (VTE) on Routine Computed Tomography (CT) Scans

Find Trials by Condition in Houston

Heart Failure Hospital Readmissions and Physical Therapy

Propranolol Hydrochloride and Chemotherapy in Treating Patients With Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

Primary Mitral Regurgitation Repair

Tivantinib in Treating Patients With Relapsed, or Relapsed and Refractory Multiple Myeloma

FOLFOX Chemotherapy Regimen (5-FU, Leucovorin, Oxaliplatin) in Metastatic Colorectal Cancer

Positive Imaging Study for Distant Metastases in Patients With Castration-Resistant Prostate Cancer

Plerixafor and Clofarabine in Frontline Treatment of Elderly Patients With Acute Myelogenous Leukemia (AML)

Expanded Access Program to Provide Treatment With Pitolisant to Adult Patients in the U.S. With Excessive Daytime Sleepiness Associated With Narcolepsy With or Without Cataplexy

Cervical Ripening for Obese Women: A Randomized, Comparative Effectiveness Trial

Health and Wellness in Healthcare Providers Post-disaster

An Extension Study to Evaluate the Long-Term Safety and Tolerability of Ubrogepant in the Treatment of Migraine

Biomarkers for Post-Transplant Lymphoproliferative Disorders in Children

Efficacy and Safety Study of PDT Using Photofrin in Unresectable Advanced Perihilar Cholangiocarcinoma (OPUS)

Comparing Complete Remission After Treatment With Selumetinib/Placebo in Patient With Differentiated Thyroid Cancer

Pivotal Study in VAP Suspected or Confirmed to be Due to Pseudomonas Aeruginosa

Data Collection of OCT and OCTA-based Ocular Measurements

A Study of Venetoclax Plus Lenalidomide and Dexamethasone for the Treatment of Newly Diagnosed t(11;14)-Positive Multiple Myeloma in Subjects Who Are Ineligible for High-Dose Therapy